CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Earnings & Estimates
NASDAQ:CELZ - US22529Y4089 - Common Stock
3.195 USD
+0 (+0.16%)
3.1206 USD
-0.07 (-2.33%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90K | 9K -90.00% | 11K 22.22% | -100.00% | 34.507M | 70.394M 104.00% | 90.743M 28.91% | 104.99M 15.70% | 116.21M 10.69% | ||
| EBITDA YoY % growth | -10.15M -233.88% | -5.526M 45.56% | -5.633M -1.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.24M -227.16% | -5.62M 45.12% | -5.744M -2.20% | -7.692M -33.91% | -8.298M -7.88% | 15.548M 287.38% | 40.448M 160.15% | 54.466M 34.66% | 64.206M 17.88% | 71.824M 11.86% | |
| Operating Margin | -11,377.78% | -62,445.56% | -52,217.27% | N/A | N/A | 45.06% | 57.46% | 60.02% | 61.15% | 61.81% | |
| EPS YoY % growth | -9.80 -111.58% | -3.69 62.35% | -3.71 -0.54% | -3.06 17.52% | -2.91 5.00% | 2.23 176.84% | 4.46 99.54% | 5.88 31.81% | 6.78 15.45% | 7.43 9.47% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.64 14.32% | -0.95 15.30% |
| Revenue Q2Q % growth | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -1.727M -55.62% | -2.56M -35.77% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.48 56.76% | -0.64 | 0.16 | 25.30% |
| Q1 2025 Q2Q % growth | -0.83 -13.70% | -0.53 | -0.30 | -56.49% |
| Q4 2024 Q2Q % growth | -1.12 5.88% | -0.64 | -0.48 | -74.29% |
| Q3 2024 Q2Q % growth | -0.75 26.47% | -0.87 | 0.12 | 13.49% |
| Q2 2024 Q2Q % growth | -1.11 -42.31% | -0.86 | -0.25 | -29.55% |
| Q1 2024 Q2Q % growth | -0.73 -4.29% | -1.17 | 0.44 | 37.77% |
| Q4 2023 Q2Q % growth | -1.19 77.55% | -1.15 | -0.04 | -3.24% |
| Q3 2023 Q2Q % growth | -1.02 -45.71% | -0.88 | -0.14 | -16.28% |
| Q2 2023 Q2Q % growth | -0.78 61.00% | -0.85 | 0.07 | 7.87% |
| Q1 2023 Q2Q % growth | -0.70 61.11% | -1.02 | 0.32 | 31.37% |
| Q4 2022 Q2Q % growth | -5.30 87.26% | -0.71 | -4.59 | -642.30% |
| Q3 2022 Q2Q % growth | -0.70 | -1.33 | 0.63 | 47.21% |
| Q2 2022 Q2Q % growth | -2.00 | -1.53 | -0.47 | -30.72% |
| Q1 2022 Q2Q % growth | -1.80 | -1.43 | -0.37 | -26.05% |
| Q4 2021 Q2Q % growth | -41.60 | -2.35 | -39.25 | -1,673.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | 3K | 3K | % | |
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 3K -85.00% | 3K | % | |
| Q3 2023 Q2Q % growth | 6K -90.00% | 6K | % | |
| Q2 2023 Q2Q % growth | 15.3K | -15.3K | -100.00% | |
| Q1 2023 Q2Q % growth | -100.00% | 30.6K | -30.6K | -100.00% |
| Q4 2022 Q2Q % growth | 20K -71.43% | 369.24K | -349.24K | -94.58% |
| Q3 2022 Q2Q % growth | 60K 500.00% | 112.2K | -52.2K | -46.52% |
| Q2 2022 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2022 Q2Q % growth | 20K | 20.4K | -400 | -1.96% |
| Q4 2021 Q2Q % growth | 70K 250.00% | 10.2K | 59.8K | 586.27% |
| Q3 2021 Q2Q % growth | 10K -87.50% | % | ||
| Q2 2021 Q2Q % growth | 10K -66.67% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | 80K 33.33% | % | ||
| Q2 2020 Q2Q % growth | 30K -50.00% | % | ||
| Q1 2020 Q2Q % growth | 40K -20.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -16.67% | 0% | -47.78% |
| Revenue | N/A | N/A | N/A | N/A |